Global Anti-Neoplastic Agents Market Research Report 2019 (Includes Business Impact of COVID-19)

  • TBI994517
  • May 03, 2019
  • Global
  • 104 pages
  • QY Market Research
                                          

"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Anti-Neoplastic Agents market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Anti-Neoplastic Agents market." Antineoplastic is a class of medicine to restrain or kill tumor cells in the body. It plays an important role in comprehensive cancer treatment, particularly for disseminated tumor and leukemia that cannot be treated with surgery. Most current antineoplastics work by inhibiting DNA or RNA synthesis, or even damaging the structure of DNA. Antineoplastics can be divided into CCNSA (Cell cycle nonspecific drug) and CCSA (Cell Cycle Specific agents) according to their different effect on tumor cells in different stages of generation cycles. Both of them have a killing effect on bone marrow hematopoietic stem cells and other cells with a short growth cycle, as well as an inhibiting effect on the bodys immune response. Factors such as growing incidence of cancer across the globe and demand for cost-effective treatment options are believed to play crucial role for the growth of global anti-neoplastic agents market. Rapid innovation in the field of personalized medicine presents a huge opportunity to manufacturers of anti-neoplastic agents. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global anti-neoplastic agents market. The global Anti-Neoplastic Agents market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Anti-Neoplastic Agents volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Neoplastic Agents market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Hoffmann-La Roche Amgen Bristol-Myers Squibb Company Baxter Boehringer Ingelheim Bayer Teva pharmaceutical Industries Johnson & Johnson Merck Pfize Accord Healthcare Lundbeck AbbVie Segment by Regions North America Europe China Japan Segment by Type Chemotherapeutic Agents Biological/Immunotherapeutic Agents Personalized Medicine Segment by Application Hospitals Clinics Cancer Rehabilitation Centers Ambulatory Surgical Centers

Table of Contents

Executive Summary
1 Anti-Neoplastic Agents Market Overview
    1.1 Product Overview and Scope of Anti-Neoplastic Agents
    1.2 Anti-Neoplastic Agents Segment by Type
        1.2.1 Global Anti-Neoplastic Agents Production Growth Rate Comparison by Type (2014-2025)
        1.2.2 Chemotherapeutic Agents
        1.2.3 Biological/Immunotherapeutic Agents
        1.2.4 Personalized Medicine
    1.3 Anti-Neoplastic Agents Segment by Application
        1.3.1 Anti-Neoplastic Agents Consumption Comparison by Application (2014-2025)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Cancer Rehabilitation Centers
        1.3.5 Ambulatory Surgical Centers
    1.4 Global Anti-Neoplastic Agents Market by Region
        1.4.1 Global Anti-Neoplastic Agents Market Size Region
        1.4.2 North America Status and Prospect (2014-2025)
        1.4.3 Europe Status and Prospect (2014-2025)
        1.4.4 China Status and Prospect (2014-2025)
        1.4.5 Japan Status and Prospect (2014-2025)
    1.5 Global Anti-Neoplastic Agents Market Size
        1.5.1 Global Anti-Neoplastic Agents Revenue (2014-2025)
        1.5.2 Global Anti-Neoplastic Agents Production (2014-2025)

2 Global Anti-Neoplastic Agents Market Competition by Manufacturers
    2.1 Global Anti-Neoplastic Agents Production Market Share by Manufacturers (2014-2019)
    2.2 Global Anti-Neoplastic Agents Revenue Share by Manufacturers (2014-2019)
    2.3 Global Anti-Neoplastic Agents Average Price by Manufacturers (2014-2019)
    2.4 Manufacturers Anti-Neoplastic Agents Production Sites, Area Served, Product Types
    2.5 Anti-Neoplastic Agents Market Competitive Situation and Trends
        2.5.1 Anti-Neoplastic Agents Market Concentration Rate
        2.5.2 Anti-Neoplastic Agents Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Neoplastic Agents Production Market Share by Regions
    3.1 Global Anti-Neoplastic Agents Production Market Share by Regions
    3.2 Global Anti-Neoplastic Agents Revenue Market Share by Regions (2014-2019)
    3.3 Global Anti-Neoplastic Agents Production, Revenue, Price and Gross Margin (2014-2019)
    3.4 North America Anti-Neoplastic Agents Production
        3.4.1 North America Anti-Neoplastic Agents Production Growth Rate (2014-2019)
        3.4.2 North America Anti-Neoplastic Agents Production, Revenue, ...
|  read more...

Request a sample

Fill below form to request a sample

Enquiry

Please fill this form to enquire before buying

Discount

You can request for discount regarding the report by using below form